ATE447403T1 - Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen - Google Patents

Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen

Info

Publication number
ATE447403T1
ATE447403T1 AT02736551T AT02736551T ATE447403T1 AT E447403 T1 ATE447403 T1 AT E447403T1 AT 02736551 T AT02736551 T AT 02736551T AT 02736551 T AT02736551 T AT 02736551T AT E447403 T1 ATE447403 T1 AT E447403T1
Authority
AT
Austria
Prior art keywords
cannabinoids
treatment
occur during
breathing disorders
during sleep
Prior art date
Application number
AT02736551T
Other languages
English (en)
Inventor
David Carley
Miodrag Radulovacki
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Application granted granted Critical
Publication of ATE447403T1 publication Critical patent/ATE447403T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02736551T 2001-04-06 2002-04-08 Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen ATE447403T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28194901P 2001-04-06 2001-04-06
PCT/US2002/010876 WO2002080903A1 (en) 2001-04-06 2002-04-08 Functional role for cannabinoids in autonomic stability during sleep

Publications (1)

Publication Number Publication Date
ATE447403T1 true ATE447403T1 (de) 2009-11-15

Family

ID=23079447

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02736551T ATE447403T1 (de) 2001-04-06 2002-04-08 Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen

Country Status (8)

Country Link
US (2) US7705039B2 (de)
EP (1) EP1372638B1 (de)
JP (1) JP5093967B2 (de)
AT (1) ATE447403T1 (de)
AU (1) AU2002309548B2 (de)
CA (1) CA2443105C (de)
DE (1) DE60234246D1 (de)
WO (1) WO2002080903A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002338329B2 (en) * 2001-03-27 2006-09-07 The Regents Of The University Of California Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
WO2004103410A1 (en) * 2002-06-06 2004-12-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods compositions and articles of manufacture for modulating bone growth
GB2394894B (en) * 2002-11-04 2005-08-31 G W Pharma Ltd New use for pharmaceutical composition
FR2862873A1 (fr) * 2003-12-01 2005-06-03 Pf Medicament Utilisation des acides gras polyinsatures omega 3 dans l'apnee du sommeil
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
WO2007047575A2 (en) * 2005-10-14 2007-04-26 The Board Of Trustees Of The University Of Illinois Pharmacological treatments for sleep-related breathing disorders
WO2007047576A1 (en) * 2005-10-14 2007-04-26 The Board Of Trustees Of The University Of Illinois Pharmacological treatments for sleep disorders
WO2007047577A2 (en) * 2005-10-14 2007-04-26 The Board Of Trustees Of The University Of Illinois Use of calcitonin-related peptide (cgrp) antagonists or release inhibitors for the treatment of sleep-related breathing disorders
WO2007098200A2 (en) 2006-02-16 2007-08-30 Imthera Medical, Inc. An rfid-based apparatus, system, and method for therapeutic treatment of obstructive sleep apnea
US20100004244A1 (en) * 2006-06-27 2010-01-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of cb2 receptor agonists for promoting neurogenesis
US20080255224A1 (en) * 2007-04-16 2008-10-16 Blum Richard S Pharmacological treatment of psoriasis
US7781650B2 (en) * 2007-04-30 2010-08-24 Monsanto Technology Llc Plants and seeds of corn variety CV202909
WO2009048581A1 (en) 2007-10-09 2009-04-16 Imthera Medical, Inc. System and method for neural stimulation
BRPI0920548B8 (pt) 2008-10-09 2021-06-22 Imthera Medical Inc aparelho para controlar posição da língua de um paciente
EP2498868A4 (de) 2009-11-10 2013-05-08 Imthera Medical Inc System zur stimulierung eines hypoglossalen nervs zur steuerung der zungenposition bei einem patienten
WO2011063164A2 (en) * 2009-11-18 2011-05-26 Steady Sleep Rx Co., Inc. Sustained release cannabinoid medicaments
MX2013005564A (es) * 2010-11-18 2014-03-12 Pier Pharmaceuticals Medicamentos de canabinoides en bajas dosis.
GB2531280A (en) * 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
US11844605B2 (en) 2016-11-10 2023-12-19 The Research Foundation For Suny System, method and biomarkers for airway obstruction
AU2019213277A1 (en) * 2018-01-29 2020-09-17 Evero Compositions and methods for treating obstructive sleep apnea
US20230000807A1 (en) * 2020-01-17 2023-01-05 Clear Lake Research, Llc Cbd oral formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0053754B1 (de) * 1980-12-06 1986-04-23 Reichert, Dietrich, Dr. med. Mittel zur Bekämpfung des Schnarchens und Verfahren zu dessen Anwendung
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
US5521215A (en) * 1989-11-07 1996-05-28 Ramot University Authority For Applied Research And Industrial Development Ltd. NMDA-blocking pharmaceuticals
US6096740A (en) * 1990-11-06 2000-08-01 Ramot University Authority For Applied Research And Industrial Development Ltd. Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions
US6211230B1 (en) * 1999-09-27 2001-04-03 The United States Of America As Represented By The Secretary Of The Army Method of reducing brain damage resulting from seizures

Also Published As

Publication number Publication date
WO2002080903A1 (en) 2002-10-17
US8207230B2 (en) 2012-06-26
JP5093967B2 (ja) 2012-12-12
JP2004532215A (ja) 2004-10-21
US7705039B2 (en) 2010-04-27
US20100137251A1 (en) 2010-06-03
EP1372638A1 (de) 2004-01-02
DE60234246D1 (de) 2009-12-17
EP1372638A4 (de) 2007-10-17
US20040127572A1 (en) 2004-07-01
AU2002309548B2 (en) 2006-08-10
CA2443105C (en) 2011-11-08
EP1372638B1 (de) 2009-11-04
CA2443105A1 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
ATE447403T1 (de) Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen
ATE324110T1 (de) Stoffe mit serotoninartiger wirkung zur behandlung der schlafapnoe
DE60223254D1 (de) Verzögert freisetzende formulierungen von oxymorphon
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DE50109156D1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
NO20052999L (no) Ny synergistisk kombinasjon omfattende roflumilast og formoterol
NO20025405D0 (no) Modulatorer for TNF-alfa-signalisering
DE59914712D1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
NO20071466L (no) 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE
NO20045343L (no) Ny kombinasjon for behandling av luftveisforstyrrelser
ATE341323T1 (de) Verwendung von darifenacin zur behandlung des harndrangs
UA83017C2 (uk) Комбінація рофлуміласту та r,r-формотеролу для лікування захворювань дихальних шляхів
NO20045344L (no) Kombinasjon for behandling av luftveisforstyrrelser
DE60305018D1 (de) Citalopram zur behandlung von bluthochdruck
EA200500538A1 (ru) Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений нервной системы
DE60108241D1 (de) Felabamat-derivate zur behandlung von neuropathischem schmerz
ATE337790T1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
DE60118363D1 (de) Methoden zur behandlung des kryptorchysmus
MXPA05012280A (es) Composiciones de una bencenosulfonamida o un metilsulfonilbenceno, inhibidores selectivos de ciclooxigenasa-2 y un agente colinergico para el tratamiento de flujo sanguineo reducido o traumatismo en el sistema nervioso central.
MXPA05012273A (es) Composiciones para el tratamiento de la reduccion del flujo sanguineo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties